p.petrov
Submits third-party assay reports on material purchased directly. Based in Antalya.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
98.74%
n=7
Suppliers covered
6
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043040 | Retatrutide | KP | KP-2607-H5219 | VendorInvestigate | 2026-Q3 | 96.13 | 5.86 | — | Laboratory-retained | 2 | FAIL |
| AX-2026-042525 | Liraglutide | ERP | ERP-2601-P6802 | Janoshik | 2026-Q2 | 98.48 | 4.40 | 95.6 | Supplier-supplied | 1 | FAIL |
| AX-2025-019073 | Tirzepatide | JEEP | JEEP-2412-U3223 | Kestrel | 2025-Q2 | 99.69 | 2.67 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020039 | BPC-157 | ERP | ERP-2502-P7707 | Janoshik | 2025-Q1 | 99.93 | 4.10 | 107.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005392 | Tirzepatide | WXT | WXT-2402-B3956 | Janoshik | 2024-Q3 | 98.74 | 3.40 | 92.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005509 | Semaglutide | BCH | BCH-2402-K7631 | Nordanalyt | 2024-Q3 | 98.41 | 3.05 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2024-005219 | IGF-1 DES (1-3) | SSA | SSA-2403-F6661 | Janoshik | 2024-Q2 | 99.93 | 3.85 | — | Supplier-supplied | 1 | MARGINAL |